Andera Partners

Portfolio Co Investors 2026 for Andera Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Andera Partners accounts for 31 tracked companies with verified cap-table data, 31 of which disclose round sizes totalling $3.8B. The median disclosed raise is $100M, and the largest is Tubulis at $575M, ahead of Alterome Therapeutics ($231M) and Alveus Therapeutics ($197M).

The names that recur most often on these co-invested cap tables are Andera Partners (31 companies), Kurma Partners (7 companies), EQT Life Sciences (5 companies), Omega Funds (5 companies), Wellington Partners (5 companies), Bpifrance (4 companies). By latest disclosed round, the market skews Series C (12), Series A (9), Series B (6), Series E (2).

Best funded Andera Partners companies

  1. Tubulis — $575M (latest: Series A)
  2. Alterome Therapeutics — $231M (latest: Series A)
  3. Alveus Therapeutics — $197M (latest: Series A)
  4. Kestra Medical Technologies, Inc. — $196M (latest: Series C)
  5. BioVentrix — $189M (latest: Series E)
  6. Artios Pharma — $186M (latest: Series C)
  7. AM Pharma — $176M (latest: Series C)
  8. ReViral — $154M (latest: IPO)
  9. ImCheck Therapeutics — $154M (latest: Series B)
  10. JenaValve Technology — $150M (latest: Series C)
  11. Adcytherix — $144M (latest: Series A)
  12. Grey Wolf Therapeutics — $131M (latest: Series B)
  13. Evommune — $115M (latest: Series C)
  14. MMI — $110M (latest: Series C)
  15. ENYO Pharma — $102M (latest: Series C)

Andera Partners — related firms and companies (56)

Andera Partners profile · All research reports